Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
In malaria parasites, digestion of host hemoglobin in the food vacuole releases **free heme**, which is normally detoxified via polymerization into hemozoin. Antimalarial drugs such as artemisinin and its derivatives exploit this free heme pool: they are activated by iron-dependent cleavage (typically Fe(II) in heme), leading to **free radical generation**. These highly reactive species cause selective damage to parasite membranes, proteins, and DNA, resulting in parasite death. Inhibition of hemozoin formation enhances the oxidative burden. The mechanism is specific to hemoglobin-digesting parasites (e.g., Plasmodium falciparum), making heme-dependent free radical generation a central target for antimalarial pharmacology[4][5][3][2][1]. Resistance mutations and host toxicity are challenges in targeting this process.
Drug activation by heme-catalyzed cleavage of endoperoxides, generating free radicals that damage parasite biomolecules[4][5][3] Inhibition of heme detoxification (hemozoin formation), augmenting oxidative burden[2]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme-dependent free radical generation (in Plasmodium parasite food vacuole).